HER2 Mutations Linked to Tumor Survival Post Hormone Therapy
Research reveals that acquired HER2 mutations confer resistance to hormone therapy in ER-positive metastatic breast cancer
Research reveals that acquired HER2 mutations confer resistance to hormone therapy in ER-positive metastatic breast cancer
Alexandra Knauer from KNAUER Wissenschaftliche Geräte swoops the award with her excellency in leadership and entrepreneurship
Read the story of a microvolume spectrophotometer demo instrument that impressed scientists so much it became the unanimous choice at the Royal Veterinary College, UK
Next-generation UPLC platform designed to keep pace with evolving laboratory requirements for chromatographic performance
Bruker and Phenomenex among those recognized at new European awards ceremony held in Munich, Germany
The INVENIO™ Fourier Transform Infrared Spectrometer offers higher performance with simpler user interface
The new portable system aims to offer a robust user experience
New discoveries on devil facial tumor suggest that human cancer drugs may reduce the cancer mortality rate of Tasmanian devils - an endangered species naive to the Australian island of Tasmania
Studies suggest that large concentrations of sulfites and bisulfites in shallow lakes may have set the stage for Earth’s first biological molecules.
The HeraSafe 2030i BSC is designed to optimize contamination control and accelerate productivity across challenging cell culture applications
Team heading to Chicago, USA, to interview scientists at the forefront of cancer research and report on the newest technologies
Managing director believes the new Pharos V8 Instrument may revolutionize PCR techniques
Dr. Adam Case monitors how T cells isolated from a mouse model of post-traumatic stress disorder kill pathogens in real time
Experts discuss the expanding role of mass spectrometry in forensic toxicology and drug monitoring research
The OEM deal aims to bring new improvements to existing equipment
Exciting new discovery describes the mechanism of action of a new class of antibiotics
A novel technique developed by Stanford scientists will transform cancer research from years of painstaking work to a task accomplished in months